DIAGNOS (DGNOF) News Today $0.19 +0.01 (+4.58%) As of 10:47 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock DGNOF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Kyndryl (NYSE:KD) and DIAGNOS (OTCMKTS:DGNOF) Critical AnalysisSeptember 10, 2025 | americanbankingnews.comDIAGNOS Announces Closing of Private PlacementSeptember 5, 2025 | globenewswire.comDIAGNOS to Extend Stock Warrants Exercise PeriodAugust 15, 2025 | globenewswire.comDIAGNOS Announces Extension of Stock Warrants Exercise PeriodAugust 13, 2025 | globenewswire.comDIAGNOS Advances into U.S. Optometry Market with FDA Pre-Submission for CARA SystemJuly 16, 2025 | tipranks.comDIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United StatesJune 10, 2025 | globenewswire.comDIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US MarketJune 4, 2025 | globenewswire.comDIAGNOS Engages Allele Capital for Strategic AdvisoryMay 23, 2025 | tipranks.comDIAGNOS Announces the Engagement of Allele Capital PartnersMay 23, 2025 | globenewswire.comDIAGNOS Announces Amendment to Convertible DebenturesMay 20, 2025 | globenewswire.comDIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System applicationApril 16, 2025 | globenewswire.comDIAGNOS Provides Additional Information on Amendment to Convertible DebenturesApril 14, 2025 | globenewswire.comDIAGNOS Provides Update on its Health Canada Medical Device Licence ApplicationApril 9, 2025 | globenewswire.comDIAGNOS Announces Amendment to Convertible DebenturesMarch 31, 2025 | globenewswire.comDIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical DeviceMarch 12, 2025 | globenewswire.comDIAGNOS Announces Amendment to Convertible DebenturesFebruary 28, 2025 | globenewswire.comDIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory SpecialistFebruary 25, 2025 | globenewswire.comCorrection - Diagnos Announces Closing of Private PlacementFebruary 14, 2025 | globenewswire.comDIAGNOS Closes $2 Million Private Placement to Boost AI Screening ServicesFebruary 5, 2025 | tipranks.comDIAGNOS Announces Closing of Private PlacementFebruary 5, 2025 | globenewswire.comDIAGNOS Announces Financial Contribution of $400,000 from the Government of CanadaJanuary 30, 2025 | globenewswire.comDIAGNOS to Present at The Microcap Conference 2025January 28, 2025 | globenewswire.comDIAGNOS Announces the Engagement of PromoterJanuary 13, 2025 | globenewswire.comOpen Thread: November 8, 2024November 8, 2024 | msn.comNorth Dakota woman shares her story about living with undiagnosed PCOS for yearsNovember 6, 2024 | msn.comNGMDF NuGen Medical Devices Inc.October 31, 2024 | seekingalpha.comDIAGNOS Announces Closing of Private PlacementOctober 25, 2024 | globenewswire.comDIAGNOS Announces the Engagement of Market Maker ConsultantOctober 17, 2024 | globenewswire.comTREIF Treatment.com AI Inc.October 16, 2024 | seekingalpha.comDIAGNOS Announces Grant of Stock OptionsOctober 3, 2024 | globenewswire.comDIAGNOS Announces Voting Results of Meeting of ShareholdersSeptember 26, 2024 | globenewswire.comDIAGNOS Announces Variation in One Insider OwnershipSeptember 23, 2024 | globenewswire.comDIAGNOS Announces Closing of Private PlacementSeptember 20, 2024 | globenewswire.comDIAGNOS Announces Date of Annual General and Special Meeting of ShareholdersAugust 22, 2024 | globenewswire.comDIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health CanadaAugust 20, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementJune 5, 2024 | globenewswire.comDIAGNOS celebrates the launch of Labtician's new screening service for diabetic retinopathy in Ontario and renews its distribution agreementMay 21, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementMay 9, 2024 | globenewswire.comDIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024May 6, 2024 | globenewswire.comDIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certificationApril 16, 2024 | globenewswire.comDIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11thApril 9, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsApril 3, 2024 | globenewswire.comDIAGNOS Welcomes Dr. Philippe Couillard to its Board of DirectorsApril 2, 2024 | globenewswire.comDIAGNOS Announces Closing of Second and Final Tranche of Private PlacementMarch 22, 2024 | globenewswire.comDIAGNOS Announces Grant of Stock OptionsMarch 4, 2024 | globenewswire.comDIAGNOS Welcomes Mr. Michael Braeuel to its Board of DirectorsFebruary 29, 2024 | globenewswire.comDIAGNOS Announces Closing of First Tranche of Private PlacementFebruary 27, 2024 | globenewswire.comDiagnos Announces Variation in One Insider Ownership of Common SharesFebruary 23, 2024 | globenewswire.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyFebruary 21, 2024 | globenewswire.comBest of 2023December 8, 2023 | nytimes.com Get DIAGNOS News Delivered to You Automatically Sign up to receive the latest news and ratings for DGNOF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DGNOF Media Mentions By Week DGNOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DGNOF News Sentiment▼0.000.73▲Average Business Services News Sentiment DGNOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DGNOF Articles This Week▼00▲DGNOF Articles Average Week Get the Latest News and Ratings for DGNOF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for DIAGNOS and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NAMI News MIND Technology News Agrify News Odysight.ai News Syntec Optics News FiscalNote News MicroCloud Hologram News Fathom News Global Mofy AI News Knightscope News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DGNOF) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWhy Peter Thiel Hid Gold in a VaultSilicon Valley billionaires hiding gold in vaults? Peter Thiel’s Palantir quietly diverted tens of millions...Golden Portfolio | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DGNOF Stock Alerts